Transfection of the miR-21 inhibitor altered mir-21 levels relative to the control by 9.4-fold and 8.5-fold in U251 and LN229 glioblastoma cells, respectively. Interestingly, taxol alone also downregulated miR-21 expression. In both LN229 and U251 glioblastoma cells, the lowest level of miR-21 expression was achieved by treatment with the miR-21 inhibitor in combination with taxol therapy.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback